Brokerages expect that IMAC Holdings, Inc. (NASDAQ:IMAC) will post earnings of ($0.15) per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for IMAC’s earnings. IMAC posted earnings per share of ($0.12) during the same quarter last year, which would suggest a negative year over year growth rate of 25%. The business is expected to announce its next earnings results on Thursday, November 11th.
According to Zacks, analysts expect that IMAC will report full year earnings of ($0.63) per share for the current fiscal year. For the next year, analysts forecast that the company will post earnings of ($0.62) per share. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that that provide coverage for IMAC.
IMAC (NASDAQ:IMAC) last issued its quarterly earnings data on Thursday, August 12th. The company reported ($0.08) EPS for the quarter, meeting the consensus estimate of ($0.08). IMAC had a negative return on equity of 43.24% and a negative net margin of 38.79%. The firm had revenue of $3.47 million during the quarter, compared to analyst estimates of $3.53 million.
Several large investors have recently bought and sold shares of the company. Warberg Asset Management LLC acquired a new stake in shares of IMAC during the 1st quarter valued at about $27,000. Resources Investment Advisors LLC. acquired a new stake in shares of IMAC during the 2nd quarter valued at about $37,000. Geode Capital Management LLC grew its position in shares of IMAC by 10.0% during the 1st quarter. Geode Capital Management LLC now owns 213,857 shares of the company’s stock valued at $352,000 after acquiring an additional 19,496 shares during the period. UBS Group AG boosted its holdings in IMAC by 300.3% in the 1st quarter. UBS Group AG now owns 26,753 shares of the company’s stock worth $44,000 after buying an additional 20,069 shares during the last quarter. Finally, Northern Trust Corp acquired a new stake in IMAC in the 2nd quarter worth about $75,000. Hedge funds and other institutional investors own 17.96% of the company’s stock.
IMAC stock remained flat at $$1.29 during midday trading on Friday. The company had a trading volume of 20,659 shares, compared to its average volume of 69,451. The firm has a market cap of $32.66 million, a PE ratio of -4.16 and a beta of -1.88. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.01. The firm has a 50-day simple moving average of $1.49 and a two-hundred day simple moving average of $1.68. IMAC has a one year low of $0.73 and a one year high of $2.75.
IMAC Company Profile
IMAC Holdings, Inc provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C.
Read More: Fibonacci Channel
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.